TMFCX | VMVAX | TMFCX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 13 years | - |
Gain YTD | 0.566 | 1.921 | 29% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 576M | 30.9B | 2% |
Annual Yield % from dividends | 0.70 | 2.14 | 33% |
Returns for 1 year | 1.41 | 12.44 | 11% |
Returns for 3 years | -2.55 | 15.34 | -17% |
Returns for 5 years | 13.15 | 38.46 | 34% |
Returns for 10 years | 25.94 | 81.26 | 32% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TQVAX | 18.04 | -0.22 | -1.20% |
T. Rowe Price Integrated US LCV Eq Adv | |||
IPLSX | 30.21 | -0.53 | -1.72% |
Voya Index Plus LargeCap Port S | |||
NGDRX | 28.76 | -0.57 | -1.94% |
Neuberger Berman Large Cap Growth R3 | |||
JGACX | 29.38 | -0.77 | -2.55% |
JPMorgan Growth Advantage C | |||
RYOTX | 10.80 | -0.31 | -2.79% |
Royce Micro-Cap Invmt |